Wednesday Aug 6
Quirks Marketing Rsch Review
How neuroscience and MR helped Bausch & Lomb develop and refine critical sales materials
A case study on the testing of detail aids for a new Bausch & Lomb contact lens shows how to effectively meld neuroscience with marketing research.
Tue Aug 05, 2014
Customer Interaction Solutions
Allergan Comments on Valeant's Second Quarter 2014 Earnings Results
Following Valeant's earnings conference call on July 31, 2014, Allergan's financial advisors and forensic accountants analyzed Valeant's reported financial and operating results, identifying numerous inconsistencies and omissions.
Fri Aug 01, 2014
Contact Lens Spectrum
Bausch + Lomb has announced that the U.S. Food and Drug Administration has issued marketing clearance for Biotrue Oneday for Presbyopia soft contact lenses.
Thu Jul 31, 2014
Valeant Pharmaceuticals posts 12-fold rise in net profit
Canada's Valeant Pharmaceuticals International Inc, which is trying to take over Botox-maker Allergan Inc, said net income rose nearly 12-fold, boosted by strong sales at its Bausch & Lomb lens business.
Tue Jul 29, 2014
U.S. Senate panel to look into price setting for contact lenses
Moves by three of the four major U.S. contact lens makers to set price floors for many of their products, preventing low-cost retailers from discounting the expensive devices, have drawn scrutiny from lawmakers.